Monkeypox Fear Fest: Is Smallpox Vaccine on Its Way Back?
This article is an excerpt from a longer fully referenced report by NVIC co-founder and president Barbara Loe Fisher on Mutated Monkeypox Outbreaks and the Anticipated Return of Smallpox Vaccine, which can be read on NVIC.org. A day before the July 4, 2024 holiday, Business Insider published an article warning that “Experts are racing to […]
Australian Judge in COVID Shot Case Failed to Disclose Ties to Pfizer
During the COVID-19 pandemic, the Government of Australia implemented very strict lockdown measures and public health policies, including mask and COVD shot mandates, curfews, school closures, and restriction of movement of people throughout the country.1 In 2021, the Western Australian Government’s Department of Health published the 2021 West Australian Vaccine Safety Surveillance (WAVSS) report that […]
Tennessee Employee Awarded Punitive Damages After Being Fired for COVID Shot Refusal
A jury awarded a settlement of $687,240 to a woman in Tennessee who was fired from her job at Blue Cross Blue Shield of Tennessee (BCBST) for refusing to comply with a COVID-19 vaccine mandate. Of the total amount, $500,000 was for punitive damages levied against BCBST.1 Tanja Benton, who worked as a biostatistical research […]
U.S. Government Gives Moderna $176 Million to Develop mRNA Bird Flu Biologic
On July 2, 2024, the U.S. government awarded a $176 million contract to Moderna, Inc. for the development of an mRNA H5N1 avian influenza biologic labeled a “vaccine,” as the media reports concerns about bird flu in dairy cows and farm workers in multiple states. The funds from the U.S. Biomedical Advanced Research and Development […]
Pfizer Sued for Misleading Claims About Its COVID Shot
The State of Kansas has sued Pfizer, Inc. over its mRNA (messenger ribonucleic acid) COVID-19 shot, Comirnaty. Kansas attorney general Kris Kobach alleges that the pharmaceutical giant labeled and marketed the novel biologic as, “safe and effective,” while knowing that the product could cause, “serious adverse events,” including myocarditis and pericarditis, failed pregnancies and death.”1 Texas […]
Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial
Reports of the nervous system disorder Guillain-Barré syndrome (GBS) were “more common than expected” in the older adult population who received the new vaccine for respiratory syncytial virus (RSV). The data, reported by the U.S. Centers for Disease Control and Prevention (CDC), matched trial data reported earlier this year.1 GBS is a “polio-like” inflammatory autoimmune […]